SeaX Ventures Leads $1.5M Pre-Seed Round to Accelerate Real-Time CT Scan Interpretation with a2z Radiology AI

What You Should Know:

–  SeaX Ventures, a $100M global deep-tech venture capital fund, today announced it has led a $1.5 million pre-seed round for a2z Radiology AI, an FDA-approved medical imaging startup delivering immediate, radiologist-level preliminary interpretations of abdominal-pelvis computed tomography (CT) scans.

–   The funding will help the company give clinicians faster, more reliable diagnostic insights.

Investing in Deep-Tech With Transformational Economic and Environmental Potential

SeaX Ventures is a global venture capital firm focused on deep-tech startups developing breakthrough technologies capable of reshaping industries. Guided by a mission to support entrepreneurs building exponential innovations, the firm prioritizes solutions with the potential to lift global GDP by 1% and cut global carbon emissions by another 1% over the next decade.
Through its extensive network of more than 500 publicly listed companies, multinational corporations, and major family businesses across Southeast Asia, SeaX provides its portfolio companies with rare access to commercial opportunities and strategic partnerships at scale.

As imaging volumes surge while the radiology workforce remains stretched, clinicians face longer turnaround times for studies that often determine urgent care pathways. a2z addresses this widening gap by giving care teams rapid, reliable preliminary interpretation that supports faster and more informed decision-making—particularly when time-sensitive decisions cannot wait.

“Radiology is central to modern medicine, but delays can slow down care when timely answers are essential,” said Dr. Kid Parchariyanon, Founder and Managing Partner of SeaX Ventures. “a2z is meeting this challenge with technology that brings expert-level support directly to clinicians. We’re proud to support a2z as they build the tools that make a meaningful difference for providers and patients.”

Founded in 2024 by Harvard Medical School associate professor Dr. Pranav Rajpurkar and technology executive Samir Rajpurkar, a2z grew out of years of research and direct engagement with radiologists, emergency physicians, and surgeons. Their conversations repeatedly highlighted the need for instant, trustworthy CT interpretation—especially during off-hours and high-pressure clinical scenarios.

a2z’s platform delivers rapid, comprehensive CT analysis that integrates seamlessly into existing clinical workflows. Instead of flagging a single condition, the system provides a broad spectrum of clinically meaningful insights to help clinicians act sooner and with greater confidence. Since debuting last year, a2z has already secured strategic partnerships with healthcare organizations and is preparing its commercial rollout for 2026.

SeaX’s investment will enable a2z to advance product development, deepen provider partnerships, and move its technology toward market readiness—bringing the industry closer to a future where expert-level diagnostic support is consistently available when it matters most.

What You Should Know:

–  SeaX Ventures, a $100M global deep-tech venture capital fund, today announced it has led a $1.5 million pre-seed round for a2z Radiology AI, an FDA-approved medical imaging startup delivering immediate, radiologist-level preliminary interpretations of abdominal-pelvis computed tomography (CT) scans.

–   The funding will help the company give clinicians faster, more reliable diagnostic insights.

Investing in Deep-Tech With Transformational Economic and Environmental Potential

SeaX Ventures is a global venture capital firm focused on deep-tech startups developing breakthrough technologies capable of reshaping industries. Guided by a mission to support entrepreneurs building exponential innovations, the firm prioritizes solutions with the potential to lift global GDP by 1% and cut global carbon emissions by another 1% over the next decade.
Through its extensive network of more than 500 publicly listed companies, multinational corporations, and major family businesses across Southeast Asia, SeaX provides its portfolio companies with rare access to commercial opportunities and strategic partnerships at scale.

As imaging volumes surge while the radiology workforce remains stretched, clinicians face longer turnaround times for studies that often determine urgent care pathways. a2z addresses this widening gap by giving care teams rapid, reliable preliminary interpretation that supports faster and more informed decision-making—particularly when time-sensitive decisions cannot wait.

“Radiology is central to modern medicine, but delays can slow down care when timely answers are essential,” said Dr. Kid Parchariyanon, Founder and Managing Partner of SeaX Ventures. “a2z is meeting this challenge with technology that brings expert-level support directly to clinicians. We’re proud to support a2z as they build the tools that make a meaningful difference for providers and patients.”

Founded in 2024 by Harvard Medical School associate professor Dr. Pranav Rajpurkar and technology executive Samir Rajpurkar, a2z grew out of years of research and direct engagement with radiologists, emergency physicians, and surgeons. Their conversations repeatedly highlighted the need for instant, trustworthy CT interpretation—especially during off-hours and high-pressure clinical scenarios.

a2z’s platform delivers rapid, comprehensive CT analysis that integrates seamlessly into existing clinical workflows. Instead of flagging a single condition, the system provides a broad spectrum of clinically meaningful insights to help clinicians act sooner and with greater confidence. Since debuting last year, a2z has already secured strategic partnerships with healthcare organizations and is preparing its commercial rollout for 2026.

SeaX’s investment will enable a2z to advance product development, deepen provider partnerships, and move its technology toward market readiness—bringing the industry closer to a future where expert-level diagnostic support is consistently available when it matters most.